Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cell therapy
cell therapy
Notch Therapeutics closes Vancouver lab, will focus on Toronto and Seattle offices
Geekwire
Tue, 08/29/23 - 11:38 am
Notch Therapeutics
Vancouver
Canada
cell therapy
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Mon, 08/28/23 - 08:21 pm
Bayer
cell therapy
Parkinson's Disease
clinical trials
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Mon, 08/28/23 - 11:37 am
Bayer
Parkinson's Disease
cell therapy
bemdaneprocel
BlueRock Therapeutics
Aspen taps tech firms for digital Parkinson's trial
Pharmaphorum
Fri, 08/25/23 - 09:45 am
Apen Neuroscience
Parkinson's Disease
cell therapy
Emerald Innovations
Rune Labs
BMS backs $255m round for contract cell maker Cellares
Pharmaphorum
Thu, 08/24/23 - 10:22 am
Cellares
funding
cell therapy
Bristol Myers Squibb
FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death
Fierce Biotech
Tue, 08/15/23 - 10:12 am
Gilead Sciences
Arcellx
CAR-T
cell therapy
FDA
Thermo Fisher lays off 200-plus at clinical-stage cell and gene therapy factory in Florida
Fierce Pharma
Mon, 08/14/23 - 06:51 pm
ThermoFisher Scientific
layoffs
gene therapy
cell therapy
FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data
BioSpace
Sun, 08/6/23 - 09:34 pm
Mesoblast
remestemcel-L
FDA
graft vs host disease
cell therapy
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center
Fierce Biotech
Fri, 08/4/23 - 12:15 pm
Vertex Pharmaceuticals
cell therapy
gene therapy
R&D
Boston
FDA rejects Mesoblast's cell therapy for bone marrow transplant complications
Yahoo/Reuters
Fri, 08/4/23 - 12:07 pm
Mesoblast
FDA
cell therapy
bone marrow transplants
remestemcel-L
3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond
Motley Fool
Fri, 07/28/23 - 10:38 am
Caribou Biosciences
cell therapy
CB-010
relapsed or refractory B cell lymphoma
Kincell spins out of a cell therapy biotech, joining wave of manufacturing startups
BioPharma Dive
Wed, 07/26/23 - 06:34 pm
Kincell
cell therapy
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
Motley Fool
Sun, 07/23/23 - 12:28 pm
cell therapy
Caribou Biosciences
CRISPR Therapeutics
Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise
BioPharma Dive
Fri, 07/21/23 - 10:10 am
IPOs
Turnstone Biologics
cell therapy
Caribou Scores Early CAR-T Lymphoma Win, Plans $125M Public Offering
BioSpace
Fri, 07/14/23 - 10:03 am
Caribou Biosciences
CAR-T
CB-010
B-cell non-Hodgkin lymphoma
cell therapy
After First Approval, Experts Point to Barriers in Cell Therapy for Type 1 Diabetes
BioSpace
Thu, 07/13/23 - 10:11 am
CellTrans
Lantidra
type 1 diabetes
cell therapy
Eli Lilly
Siglion Therapeutics
Following in Biogen's wake, BrainStorm analyzes effect of ALS cell therapy on biomarker
Fierce Biotech
Fri, 07/7/23 - 08:40 am
BrainStorm Cell Therapeutics
ALS
cell therapy
Biogen
NurOwn
Tessa Therapeutics dissolves after raising more than $200M
Fierce Biotech
Thu, 07/6/23 - 09:59 pm
Tessa Therapeutics
cell therapy
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments
Yahoo/Reuters
Thu, 06/29/23 - 11:56 am
Eli Lilly
M&A
Sigilon
cell therapy
diabetes
FDA blesses CellTrans' Lantidra, the first cell therapy for Type 1 diabetes
Fierce Pharma
Thu, 06/29/23 - 11:24 am
CellTrans
Lantidra
donislecel
cell therapy
type 1 diabetes
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »